Vistin Pharma ASA operates within the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Vistin Pharma ASA with three other
companies in this sector in NORWAY :
sales of 281.56 million Norwegian Kroner [US$30.96 million]
of which 52%
was Hexvix/Cysview Own Sales),
(127.12 million Norwegian Kroner [US$13.98 million]
of which 100%
was Vitamin K2/MenaQ7), and
(83.94 million Norwegian Kroner [US$9.23 million]
During the year ended December of 2019, sales at
Vistin Pharma ASA were NOK 227.19 million (US$24.98 million).
increase of 14.2%
versus 2018, when the company's sales were NOK 198.99 million.